Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 4/20 | 0.41 |
| ▸ | RAB9A | P51151 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | RAF1 | P04049 | 1/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6894457 | 0.87 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2KMT2AMAPTMEN1 | |
| SCHEMBL6896387 | 0.85 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2HPGDNPC1RAB9A | |
| SCHEMBL5583370 | 0.77 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2HPGDNPC1RAB9A | |
| SCHEMBL5583434 | 0.77 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2NPC1RAB9AMAPT | |
| SCHEMBL28555839 | 0.75 | SMN1; SMN2 (0.50) | ALDH1A1SMN1; SMN2HPGDNPC1RAB9A | |
| SCHEMBL5595476 | 0.74 | CYP1A2 (0.56) | ALDH1A1SMN1; SMN2HPGDNPC1RAB9A | |
| SCHEMBL3291004 | 0.74 | CYP1A2 (0.50) | ALDH1A1SMN1; SMN2KMT2AMAPTMEN1 | |
| SCHEMBL6895354 | 0.74 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A | |
| SCHEMBL7802203 | 0.74 | SMN1; SMN2 (0.49) | ALDH1A1SMN1; SMN2HPGDNPC1RAB9A | |
| SCHEMBL3689755 | 0.73 | ALDH1A1 (0.49) | ALDH1A1SMN1; SMN2HPGDNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040242653-A1 | Photolabile esters and their uses | THE INSTITUTE OF CANCER RESEARCH (GB) | 2004-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242653-A1 | Photolabile esters and their uses | DIMT1, DCTD, DTYMK | ALDH1A1 2920/4885SMN1; SMN2 1085/4885HPGD 4227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.